Currently out of the existing stock ratings of Robert Wasserman, 33 are a BUY (82.5%), 7 are a HOLD (17.5%).

Robert Wasserman

Work Performance Price Targets & Ratings Chart

Analyst Robert Wasserman works at BENCHMARK with a stock forecast success ratio of 1.82% fulfilled within 23.73 days on average.

Robert Wasserman’s has documented 69 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on LGND, Ligand Pharmaceuticals orporated at 12-Apr-2024.

Wall Street Analyst Robert Wasserman

Analyst best performing recommendations are on LGND (LIGAND PHARMACEUTICALS ORPORATED).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS ORPORATED) at 2/22/2022. The price target of $81.1 was fulfilled within 261 days with a profit of $17.6 (27.72%) receiving and performance score of 1.06.

AERC Aeroclean Technologies LLC DHR Danaher PRLB Proto Labs EBS Emergent Biosolutions IPA Immunoprecise Antibodies Ltd LGND Ligand Pharmaceuticals orporated ABCL Abcellera Biologics CDXS Codexis HALO Halozyme Therapeutics RGEN Repligen TECH Bio-Techne Corp

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Robert Wasserman (BENCHMARK)

Buy

$5.04 (257.14%)

1 years 8 months 7 days ago

0/1 (0%)

$2.29 (48.62%)

Please subscribe to see the analyst performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Robert Wasserman is most bullish on?

Potential upside of $24 has been obtained for LGND (LIGAND PHARMACEUTICALS ORPORATED)

Which stock is Robert Wasserman is most reserved on?

Potential downside of -$0 has been obtained for ABCL (ABCELLERA BIOLOGICS )

What Year was the first public recommendation made by Robert Wasserman?

On 2020